Rick Simpson Oil (RSO) in St. Kitts and Nevis: A Complete Guide by OilWell Cannabis

Why This Guide Matters for St. Kitts and Nevis

St. Kitts and Nevis is a place of vibrant culture, warm communities, and deep traditions—where family, health, and well-being are central to daily life. Yet, like many Caribbean nations, access to advanced medical treatments can be limited, and chronic conditions such as pain, insomnia, anxiety, and the side effects of serious illnesses like cancer often leave residents searching for alternatives.

For those in St. Kitts and Nevis exploring Rick Simpson Oil (RSO)—whether for personal use, a loved one, or simply out of curiosity—this guide is designed to provide clear, honest, and science-backed education about what RSO is, how it differs from traditional cannabis oils, and how modern formulations like OilWell’s RSO can offer safer, more precise, and more accessible options.

We’ll cover:
✅ What RSO is (and isn’t)—honest history, not hype
✅ How modern RSO differs from traditional methods—safety, precision, and legal access
✅ The science behind the cannabinoids and terpenes in OilWell’s formula
✅ How to use RSO safely and effectively in St. Kitts and Nevis
✅ Legal and practical considerations for purchasing and using RSO in the Caribbean
✅ Why OilWell’s open-source, evidence-based approach sets a new standard

This isn’t just another cannabis product page. It’s a comprehensive, culturally relevant resource—written for the people of St. Kitts and Nevis, with respect for local values, health realities, and the need for trustworthy information.

Chapter 1: What Is Rick Simpson Oil (RSO)?

The Origin Story: Rick Simpson and the Birth of RSO

Rick Simpson was a Canadian power engineer—not a doctor, scientist, or medical professional. His journey into cannabis began not with research, but with personal suffering and a deep distrust of a medical system that failed him.

In 1997, while working at a hospital in New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications he was prescribed either didn’t help or made things worse. When he asked his doctor about cannabis for relief, the request was refused.

Simpson’s interest in cannabis deepened after he learned about a 1974 study funded by the U.S. National Institutes of Health (NIH), in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment in Simpson’s story came in 2003, when he reported that three bumps on his arm were diagnosed as basal cell carcinoma (a type of skin cancer). Instead of pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days.

Important context:
Simpson’s personal experience was not medically verified. There was no independent confirmation, no biopsy, and no peer-reviewed documentation of the outcome. However, this moment became the origin story of Rick Simpson Oil (RSO)—the catalyst for a global movement around concentrated cannabis oil.

The Crusade: How RSO Went Global

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil for free. Operating from his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away to cancer patients and others in his community. He charged nothing, believing that cannabis oil should be accessible to everyone who needed it.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, featured testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. It was distributed freely online and became one of the most widely shared cannabis advocacy films of its era—many people’s first introduction to the concept of concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking. Despite community support and public attention, he was convicted on some charges. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, where he continued his advocacy from abroad.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, a book detailing his personal experience, his oil-making process, and his broader philosophical views on cannabis, medicine, and institutional suppression. He also maintained phoenixtears.ca as his primary online platform for information and advocacy.

The Traditional RSO Protocol: What Simpson Recommended

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams (approximately 60 mL) of concentrated cannabis oil over 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions, including chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

Here’s how the traditional protocol worked:

Goal:

Consume 60 grams of high-THC cannabis oil over approximately 90 days.

Titration Schedule (Dose Escalation):

• Week 1: Begin with a dose the size of half a grain of rice (roughly 10–15 mg of oil) taken three times per day (morning, afternoon, and before bed). Total daily intake: 30–45 mg.
• Weeks 2–5: Gradually double the dose every four days to build THC tolerance. By the end of this period (roughly 4–5 weeks in), the target was 1 gram (1,000 mg) of oil per day, divided into three doses.
• Weeks 5–12: Maintain the full dose of 1 gram per day (about 333 mg per dose) until the full 60 grams were consumed.

Administration Methods:

• Primary (oral): Place the dose under the tongue (sublingual) or swallow it.
• Secondary (topical): For skin cancers, apply the oil directly to the affected area and cover with a bandage, changing every 3–4 days.
• Not recommended as primary: Inhalation (smoking/vaping) was acknowledged for immediate symptom relief but not considered essential for treatment.

Tolerance and Psychoactive Effects:

• Simpson maintained that patients would develop tolerance to the psychoactive effects of THC within 3–4 weeks.
• He recommended taking initial doses at night to sleep through the most intense effects.
• He warned against driving or operating machinery during the titration period.

Post-Protocol Maintenance:

• After completing the 60-gram course, Simpson recommended a maintenance dose of 1–2 grams per month, taken indefinitely.

Dietary and Lifestyle Recommendations:

• Simpson also advocated for reducing sugar, avoiding processed foods, and improving nutrition alongside the oil protocol.

The Reality of Traditional RSO: Strengths and Serious Risks

Simpson’s protocol was designed by one person based on personal experience and anecdotal observations—not through clinical trials, scientific research, or formal medical oversight. While his story inspired millions, it’s important to evaluate traditional RSO with clear eyes.

What Traditional RSO Was:

• A crude, THC-dominant extract made from a single high-THC indica strain.
• Extracted using naphtha or 99% isopropyl alcohol—neither of which is food-grade or safe for internal use.
• Fully decarboxylated (all THCa converted to delta-9 THC) due to the high heat used in solvent evaporation.
• No terpenes—these were destroyed by the solvent and heat.
• No lab testing or standardization—every batch was different.
• No Certificate of Analysis (COA)—no way to verify potency, purity, or contaminants.

The Risks:

1. Extremely high THC exposure:

   • At peak dosing, patients were consuming 600–900 mg of delta-9 THC per day—far exceeding anything studied in clinical settings. For comparison, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5–20 mg per day.
   • This level of THC carries serious risks, including severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder.

2. Residual solvent risk:

   • Naphtha (a petroleum-based solvent) may contain benzene, toluene, and other carcinogens.
   • Isopropyl alcohol is not food-grade.
   • Incomplete solvent purging—difficult to verify without lab testing—leaves potentially harmful residues in the oil.

3. No clinical validation:

   • No randomized controlled trials, cohort studies, or peer-reviewed evidence supports the 60-gram/90-day protocol for any condition.
   • Simpson’s evidence was personal testimony and anecdotal reports—valuable as inspiration, but not medical proof.

4. Oncology context:

   • Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment—potentially in place of proven therapies—introduces serious harm potential.

Chapter 2: How Modern RSO Differs from Traditional RSO

The Evolution of RSO: From Crude Oil to Precision Medicine

The term “RSO” has become generic—used to describe almost any full-spectrum cannabis extract, regardless of how it’s made. But modern RSO has evolved dramatically from Simpson’s original method, addressing its most serious limitations while preserving its core philosophy: accessible, full-spectrum cannabis medicine.

Here’s how OilWell’s RSO differs from traditional RSO:

Why OilWell’s Formula Diverges from Traditional RSO

OilWell’s RSO is not traditional RSO. It’s a modern, evidence-informed evolution of the concept—designed to solve the problems that limited Simpson’s original vision.

1. Multi-Cannabinoid Approach

• Traditional RSO: Relied on whatever single strain the maker grew or sourced. THC content varied widely (60–90%).
• OilWell RSO: Intentionally includes seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage effect literature suggests potential benefit from cannabinoid diversity.

2. Terpene Preservation and Addition

• Traditional RSO: Had no terpenes—destroyed by solvent and heat.
• OilWell RSO: Includes live terpenes at 5% with a defined seven-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene). Terpenes contribute to flavor, aroma, and potential therapeutic effects.

3. THCa as a Separate Ingredient

• Traditional RSO: Fully decarboxylated—all THCa converted to THC.
• OilWell RSO: Preserves 1,500 mg of THCa as a distinct ingredient. This allows for patient-controlled potency:
  • Raw (no heat): Non-psychoactive. Useful for daytime anti-inflammatory benefits without impairment.
  • Decarboxylated (heated at home): Converts THCa to delta-9 THC (~1,315 mg) for full psychoactive potency.
  • Vape (auto-decarboxylation): Instant conversion with every puff.

4. Reduced Delta-9 THC Dominance

• Traditional RSO: 60–90% delta-9 THC.
• OilWell RSO: Only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg/mL), with 6,000 mg delta-8 THC and the remaining cannabinoids distributed across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reduces intoxication risk while maintaining therapeutic potential.

5. Product Format Innovation

• Traditional RSO: Only one format—oral oil.
• OilWell RSO: Two formats for different needs:
  • Sublingual oil (30 mL, 16,590 mg total cannabinoids): For sustained relief (4–6 hour duration).
  • Vape cartridge (1 g, 900+ mg total cannabinoids): For fast relief (1–2 minute onset).

Chapter 3: The Science Behind OilWell’s RSO Formula

Why Seven Cannabinoids? The Evidence for Each

OilWell’s RSO formula includes seven cannabinoids, each with its own evidence profile and potential therapeutic role. Here’s what the science says about each one—and how it may benefit people in St. Kitts and Nevis.

1. CBD (Cannabidiol) – 4,500 mg

• Strongest human evidence in the formula, especially for seizure disorders (FDA-approved Epidiolex).
• Anxiety: A 2024 meta-analysis found a statistically significant anxiolytic effect in clinical trials, though more research is needed.
• Pain: A 2024 systematic review concluded that CBD shows promise for chronic pain, but trial quality and consistency remain limitations.
• Safety: Generally well-tolerated, but may cause diarrhea, sleepiness, or liver enzyme elevation in some people.

2. CBG (Cannabigerol) – 3,000 mg

• Emerging research suggests potential for neurologic disorders, inflammatory bowel disease, and antibacterial activity.
• Pharmacology: Interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling.
• Caution: Already sold commercially despite limited clinical validation.

3. Delta-8 THC – 6,000 mg

• Psychoactive but less potent than delta-9 THC (partial CB1 agonist).
• Pharmacology: Similar to delta-9 THC but with weaker CB1 affinity, which may reduce intoxication risk.
• Public health concerns: A 2023 scoping review noted adverse event reports and regulatory concerns due to manufacturing variability.

4. THCa (Tetrahydrocannabinolic Acid) – 1,500 mg

• Non-psychoactive precursor to THC. Must be decarboxylated (heated) to convert to delta-9 THC.
• Potential benefits (preclinical):
  • Anti-inflammatory (COX-2 inhibition)
  • Neuroprotective (PPARγ agonism)
  • Antineoplastic (cancer cell studies)
• Key advantage: Allows for patient-controlled potency—use raw for daytime, decarb for nighttime.

5. Delta-9 THC – 90 mg

• Strongest human evidence for:
  • Chemotherapy-related nausea and vomiting
  • Appetite stimulation in HIV/AIDS
  • Chronic pain (though with side effects like dizziness and sedation)
• Risks:
  • Anxiety, panic, tachycardia, blood pressure changes
  • Impairment (do not drive or operate machinery)
  • Cannabis use disorder potential

6. CBN (Cannabinol) – 750 mg

• Marketed as a sleep aid, but human evidence is weak.
• A 2021 review found no clinical trials using validated sleep measures to support strong sleep-promoting claims.
• Preclinical evidence suggests possible sedative effects, but not enough to justify firm claims.

7. CBC (Cannabichromene) – 750 mg

• Emerging research suggests potential for:
  • Antinociceptive (pain-relieving) effects
  • Antibacterial activity
  • Anti-seizure effects
• Caution: Already sold commercially despite limited clinical evidence.

Why Terpenes Matter: The Seven-Terpene Profile

OilWell’s RSO includes live terpenes at 5%, with a defined profile of seven terpenes. While human clinical evidence for cannabis-specific terpene effects is still developing, preclinical and review literature suggest potential benefits.

Important note: While terpenes are biologically active and contribute to the entourage effect, strong clinical proof for cannabis-specific terpene effects in humans is still limited. Claims should be conservative and evidence-based.

Chapter 4: How to Use OilWell RSO in St. Kitts and Nevis

Product Formats: Sublingual Oil vs. Vape Cartridge

OilWell offers RSO in two formats, each designed for different needs:

When to Use Each Format

Condition-Specific Usage Contexts

Important disclaimer:
The following usage contexts are informed by cannabinoid research and OilWell’s formulation rationale. They are not medical prescriptions, FDA-approved treatment protocols, or a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns.

1. Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5–1.0 mL sublingual approximately 1 hour before treatment.
• Acute breakthrough nausea: 2–3 vape puffs for immediate relief (1–2 minute onset).
• Post-chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep support during treatment: 1.0–2.0 mL sublingual before bed (delivers 25–50 mg CBN).
• Evidence context:
  • Delta-8 THC: Antiemetic evidence
  • Delta-9 THC: Nausea and vomiting evidence
  • CBD: Anxiolytic buffering

2. Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3–0.5 mL raw sublingual (non-psychoactive, anti-inflammatory).
• Nighttime: 0.5–1.0 mL decarboxylated sublingual (combines pain relief with CBN sleep support).
• Breakthrough pain: Vape as needed for rapid onset.
• Evidence context:
  • CBD: Pain evidence
  • Delta-9 THC: Pain evidence
  • Beta-caryophyllene: CB2 agonism (anti-inflammatory)
  • THCa: COX-2 inhibition

3. Sleep Support

• Before bed: 1.0–2.0 mL sublingual.
  • At 2.0 mL: Delivers 50 mg CBN (dosage level investigated in sleep literature).
  • At 1.0 mL: Delivers 25 mg CBN (above the 20 mg threshold associated with reduced sleep disturbance).
• Evidence context:
  • CBN: Sleep evidence (though weak)
  • Cannabis and sleep review literature

4. Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual (CBD and CBG address anxiety without impairment).
• Nighttime: 1.0 mL sublingual (full cannabinoid profile including CBN for sleep architecture).
• Evidence context:
  • CBD: Anxiety evidence
  • CBG: Pharmacology
  • Limonene: Entourage effect evidence

General Titration Principle: Start Low, Go Slow

• Begin with 0.25–0.5 mL sublingual and assess effects over 2–3 hours before increasing.
• Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Chapter 5: Legal and Practical Considerations for St. Kitts and Nevis

Is RSO Legal in St. Kitts and Nevis?

Cannabis Laws in St. Kitts and Nevis

As of 2024, St. Kitts and Nevis has decriminalized small amounts of cannabis for personal use but has not legalized recreational or medical cannabis in the same way some other Caribbean nations (e.g., Jamaica, Antigua and Barbuda) have.

• Decriminalization: In 2019, St. Kitts and Nevis decriminalized the possession of up to 15 grams of cannabis for personal use. Possession of small amounts is no longer punishable by imprisonment, but fines may still apply.
• No legal recreational or medical market: There are no licensed dispensaries for cannabis products, including RSO.
• Cultivation: Growing cannabis, even for personal use, remains illegal.
• THC content: The law does not distinguish between hemp-derived products (low-THC) and marijuana-derived products (high-THC). All cannabis products are treated similarly under the law.

How OilWell’s RSO Fits Into This Framework

OilWell’s RSO is hemp-derived and contains less than 0.3% delta-9 THC at the point of sale—making it legal under the 2018 U.S. Farm Bill. However, St. Kitts and Nevis does not have a formal hemp regulatory framework, so the legal status of hemp-derived products is unclear.

• THCa and decarboxylation: OilWell’s RSO contains 1,500 mg of THCa, which can be converted to ~1,315 mg of delta-9 THC when heated. This means the same product can function as non-psychoactive or full-potency psychoactive, depending on how it’s used.
  • Raw (no heat): Contains only 90 mg delta-9 THC (well under 0.3%)—likely legal.
  • Decarboxylated (heated): Contains ~1,405 mg delta-9 THC—this would be considered high-THC cannabis oil and would not be legal in St. Kitts and Nevis.
• Customer responsibility: OilWell ships with full documentation (COAs, receipts), but the customer is responsible for complying with local laws. If you choose to decarboxylate the oil in St. Kitts and Nevis, you are doing so at your own legal risk.

Practical Recommendations for St. Kitts and Nevis Residents

1. Use the oil in its raw (non-decarboxylated) form to stay within the legal low-THC threshold.
2. Avoid decarboxylating the oil unless you are in a private setting and fully understand the legal risks.
3. Do not travel with the oil if it has been decarboxylated—this could be considered possession of high-THC cannabis oil.
4. Consult local legal advice if you have questions about the current status of cannabis laws in St. Kitts and Nevis.

How to Purchase OilWell RSO in St. Kitts and Nevis

OilWell ships nationwide in the U.S. and internationally, including to St. Kitts and Nevis. Here’s how it works:

1. Ordering Online

• Visit OilWell’s RSO product page.
• Select RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99).
• Complete checkout with your shipping address in St. Kitts and Nevis.

2. Shipping and Customs

• International shipping: OilWell ships to St. Kitts and Nevis with full documentation (COAs, receipts).
• Customs risk: The customer is responsible for verifying local laws and accepting customs risk. OilWell cannot guarantee that packages will clear customs.
• Shipping cost: A flat international shipping fee applies. Excessive customs fees or duties are the responsibility of the customer.
• Delivery time: Typically 7–14 business days via international courier.

3. Payment

• OilWell accepts credit/debit cards and other secure payment methods.
• All transactions are discreet—no cannabis-related terms appear on bank statements.

4. Customer Support

• If you have questions about ordering, shipping, or product use, contact OilWell at:
  • Phone: (832) 416-2816
  • Email: [email protected]

Chapter 6: Why OilWell’s Approach Matters for St. Kitts and Nevis

1. Open-Source Formulas: Accessibility for Everyone

OilWell publishes complete formulas for their RSO products—every cannabinoid, every milligram amount, every percentage. If you can’t afford the product, you can source the ingredients and make your own version.

This is a direct echo of Rick Simpson’s original ethos—he gave his oil away for free and taught people how to make it. OilWell adapted that ethos for the modern era:

• Sell a professionally manufactured, lab-tested product for those who want it.
• Publish the complete recipe for those who want to make it themselves.

For St. Kitts and Nevis, where access to medical cannabis is limited, this open-source approach ensures that no one is shut out—whether due to cost, legal barriers, or lack of local suppliers.

2. Evidence-Informed, Not Evidence-Overstating

OilWell’s RSO is anchored to per-compound evidence summaries—the same peer-reviewed research cited throughout this guide. Where the science is strong (e.g., CBD for seizures), they say so confidently. Where it’s emerging (e.g., CBG for neurologic disorders), they say so honestly. Where it’s weak (e.g., CBN for sleep), they acknowledge the gap.

This honesty is rare in the cannabis industry, where marketing often outpaces science. For St. Kitts and Nevis, where misinformation about cannabis is common, OilWell’s evidence-based approach provides trustworthy education.

3. Patient-Controlled Potency: Freedom to Choose

OilWell’s RSO contains 1,500 mg of THCa, which can be:

• Used raw for non-psychoactive anti-inflammatory benefits (daytime use).
• Decarboxylated at home for full psychoactive potency (nighttime use).
• Vaped for instant decarboxylation (acute relief).

This flexibility is especially valuable in St. Kitts and Nevis, where:

• Work, driving, and daily responsibilities require non-psychoactive options.
• Nighttime relief may benefit from psychoactive effects.
• Legal risks make it important to control THC exposure.

4. Solvent-Free, Lab-Tested: Safety First

Traditional RSO used naphtha or isopropyl alcohol—neither of which is food-grade. OilWell’s RSO is solvent-free, using organic MCT oil as the carrier. It’s also third-party lab tested for:

• Potency (cannabinoids and terpenes)
• Pesticides (400+ compounds screened)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (none detected)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

For St. Kitts and Nevis, where product quality can be inconsistent, this testing ensures safety and reliability.

5. Community Commitment: More Than a Business

OilWell’s story is rooted in community and compassion:

• Bentley’s story: The company began when Colin Valencia used CBD to save his paralyzed dog from euthanasia.
• Colin’s story: He used cannabinoids to quit benzodiazepines cold turkey and developed the Peace Gummies formula during his withdrawal.
• Community action: OilWell donated $35,000 in product to encourage COVID-19 vaccination in Houston.

For St. Kitts and Nevis, where community and family are central, OilWell’s values resonate deeply.

Final Thoughts: RSO in St. Kitts and Nevis—Hope, Science, and Responsibility

Rick Simpson Oil (RSO) has inspired millions around the world—offering hope to those who feel failed by conventional medicine. But hope must be grounded in science, safety, and responsibility.

For the people of St. Kitts and Nevis, OilWell’s RSO represents a modern evolution of RSO—one that:
✅ Preserves the spirit of accessibility (open-source formulas, no medical card required).
✅ Prioritizes safety (solvent-free, lab-tested, precise dosing).
✅ Respects the science (evidence-informed, not evidence-overstating).
✅ Offers flexibility (patient-controlled potency, two product formats).
✅ Supports the community (values-driven, not just profit-driven).

If you’re in St. Kitts and Nevis exploring RSO—whether for pain, sleep, anxiety, or another reason—we encourage you to:

1. Start with the raw (non-decarboxylated) oil to stay within legal limits.
2. Consult a healthcare provider before use, especially if you have a medical condition or take medications.
3. Use responsibly—start low, go slow, and avoid driving or operating machinery if using psychoactive forms.
4. Stay informed about local laws and any changes to cannabis regulations in St. Kitts and Nevis.

OilWell’s RSO is not a cure-all, but it is a thoughtfully designed, evidence-informed tool—one that may offer relief, support, and a new path forward for those who need it.

For more information or to place an order, visit:
🌐 OilWell RSO Product Page
📞 (832) 416-2816
✉️ [email protected]

We’re here to help. Whether you’re in Basseterre, Charlestown, Sandy Point, or anywhere else in St. Kitts and Nevis—our team is ready to answer your questions and support your journey.